Figure 6.

Changes in mean DLQI scores in response to BMVP treatment at baseline (visit 1) and at the end of treatment (visit 2). Reproduced under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/) from Maccari F. Improvement of inflammatory dermatoses severity and quality of life in patients treated with a betamethasone valerate plaster (LIBERE study). J Dermatolog Treat. 2016;27:59–63.

BMVP, betamethasone valerate medicated plaster; DLQI, dermatology life quality index.